Histology of the tumor specimen confirmed a somatotroph tumor and somatostatin (SST) receptor subtyping using an immunoreactivity score (IRS) of 17 to 18, membranous expression of IRS 1 for SST2 receptor and IRS of 12 for SST5 receptor. This evidence concerns the gene SST and neoplasm.